Circulating Levels of Secretory Type II Phospholipase A 2 Predict Coronary Events in Patients with Coronary Artery Disease
- 21 September 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (12), 1280-1284
- https://doi.org/10.1161/01.cir.100.12.1280
Abstract
Background—The circulating levels of secretory nonpancreatic type II phospholipase A2 (sPLA2) are increased in various chronic inflammatory diseases and the increase in the levels correlates with t...Keywords
This publication has 19 references indexed in Scilit:
- Atherogenesis and Ischemic Heart DiseaseThe American Journal of Cardiology, 1997
- Secretory group II phospholipase A2 in human atherosclerotic plaquesAtherosclerosis, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells.Journal of Clinical Investigation, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cellsFEBS Letters, 1990
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- Immune mechanisms in atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- The primary structure of a membrane-associated phospholipase A2 from human spleenBiochemical and Biophysical Research Communications, 1989